{"entity":{"type":"insider","cik":"0001511792","url":"/insider/0001511792","json_url":"/insider/0001511792.json","name":"Lander Russel J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":2,"first":"2011-02-03","last":"2011-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Lander Russel J","source":"filing","n_filings":2,"first_seen":"2011-02-03","last_seen":"2011-03-03"}],"transactions":[{"id":8990776,"accession":"0001511792-11-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001511792-11-000003","line_url":"/filing/0001511792-11-000003","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001511792","owner_name":"Lander Russel J","owner_display_name":"Lander Russel J","owner_url":"/insider/0001511792","role":"Officer (VP of Process/QualityAssurance)","role_mark":"O","role_mark_label":"Officer (VP of Process/QualityAssurance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Process/QualityAssurance","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.45975,"price_display":"0.46","price_state":"stated","total_value":22987.5,"total_display":"22,987.50","total_whole":"22,988","shares_owned_after":182983.0,"shares_owned_after_display":"182,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-03","scope":"insider","n_lines":2},{"id":9095783,"accession":"0001511792-11-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001511792-11-000002","line_url":"/filing/0001511792-11-000002","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001511792","owner_name":"Lander Russel J","owner_display_name":"Lander Russel J","owner_url":"/insider/0001511792","role":"Officer (VP of Process/QualityAssurance)","role_mark":"O","role_mark_label":"Officer (VP of Process/QualityAssurance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Process/QualityAssurance","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1460.0,"shares_display":"1,460","price_per_share":0.5086301369863013,"price_display":"0.51","price_state":"stated","total_value":742.6,"total_display":"742.60","total_whole":"743","shares_owned_after":157783.0,"shares_owned_after_display":"157,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-23","filed_date":"2011-02-03","scope":"insider","n_lines":2},{"id":9095781,"accession":"0001511792-11-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001511792-11-000002","line_url":"/filing/0001511792-11-000002","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001511792","owner_name":"Lander Russel J","owner_display_name":"Lander Russel J","owner_url":"/insider/0001511792","role":"Officer (VP of Process/QualityAssurance)","role_mark":"O","role_mark_label":"Officer (VP of Process/QualityAssurance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Process/QualityAssurance","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":1300.0,"total_display":"1,300.00","total_whole":"1,300","shares_owned_after":155523.0,"shares_owned_after_display":"155,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-23","filed_date":"2011-02-03","scope":"insider","n_lines":2},{"id":9095779,"accession":"0001511792-11-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001511792-11-000002","line_url":"/filing/0001511792-11-000002#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001511792","owner_name":"Lander Russel J","owner_display_name":"Lander Russel J","owner_url":"/insider/0001511792","role":"Officer (VP of Process/QualityAssurance)","role_mark":"O","role_mark_label":"Officer (VP of Process/QualityAssurance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Process/QualityAssurance","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":950.0,"shares_display":"950","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":446.5,"total_display":"446.50","total_whole":"447","shares_owned_after":154023.0,"shares_owned_after_display":"154,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-16","filed_date":"2011-02-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000946644","name":"HEMISPHERX BIOPHARMA INC","url":"/issuer/0000946644","role":"Officer (VP of Process/QualityAssurance)","n_filings":2,"first_seen":"2011-02-03","last_seen":"2011-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001511792","retrieved_at":"2026-08-26T18:49:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}